Manifestasi Klinis dan Komplikasi Infeksi Dengue pada Anak-Anak: Wawasan dan Perbandingan dengan Kasus pada Dewasa
Tinjauan Pustaka
DOI:
https://doi.org/10.55175/cdk.v52i8.1518Kata Kunci:
Anak-anak, komplikasi, demam dengue, demam berdarah dengue, sindrom syok dengueAbstrak
Demam dengue, demam berdarah dengue, dan sindrom syok dengue telah menjadi masalah kesehatan global yang signifikan, terutama karena anak-anak mengalami dampak yang lebih berat dibandingkan orang dewasa. Pada anak-anak, infeksi dengue berbeda dengan pada orang dewasa karena tingkat mortalitas yang lebih tinggi serta risiko yang meningkat untuk berkembang menjadi demam berdarah dengue atau sindrom syok dengue. Manifestasi klinis bervariasi menurut usia; anak-anak lebih sering mengalami muntah, ruam, dan nyeri perut, sedangkan orang dewasa umumnya mengalami nyeri otot dan sendi. Gejala DHF, jenis infeksi demam berdarah yang parah, meliputi gangguan hemostasis, kebocoran plasma, dan sindrom syok kehilangan protein (sindrom syok demam berdarah/DSS). Infeksi dengue pada anak dapat menyebabkan berbagai komplikasi pada setiap sistem organ. Pada fase kritis, anak-anak rentan mengalami kebocoran plasma, syok, dan perdarahan, yang berpotensi menyebabkan komplikasi berat seperti disfungsi hati, ketidakseimbangan elektrolit, dan kegagalan organ. Penanganan dan pencegahan dengue yang tepat sangat diperlukan untuk mencegah terjadinya komplikasi akibat dengue.
Unduhan
Referensi
Schaefer TJ, Panda PK, Wolford RW. Dengue fever. StatPearls [Internet]. 2024 [cited 2024 Jul 29]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK430732/.
Mikhael K, Husada D, Lestari P. Profile of dengue fever complication in infant at tertiary referral hospital in East Java, Indonesia. Biomolecular and Health Science Journal. 2022 Apr 28;5(1):11–5. doi: 10.20473/bhsj.v5i1.34827.
World Health Organization, Regional Office for South-East Asia. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. New Delhi: WHO Regional Office for South-East Asia; 2011 .p. 196.
Halstead SB. Dengue fever and dengue hemorrhagic fever. In: Kliegman RM, Geme JW, editors. Nelson textbook of pediatrics. 20th ed. Philadelphia: Elsevier Health Sciences; 2019. p. 1629-32.
Florez JES, Velasquez KM, Cardona AMS, Jaramillo BNR, Diaz YEO, Cardona LSG, et al. Clinical manifestations of dengue in children and adults in a hyperendemic region of Colombia. AJTMH [Internet]. 2024 [cited 2024 Jul 29]. Available from: https://www.ajtmh.org/view/journals/tpmd/110/5/article-p971.xml.
Badan Kebijakan Pembangunan Kesehatan, BKPK Kementerian Kesehatan Republik Indonesia. SKI 2023 dalam angka [Internet]. Jakarta: BKPK Kemenkes; 2023 [cited 2024 Jul 29]. Available from: https://www.badankebijakan.kemkes.go.id/ski-2023-dalam-angka/.
Mishra S, Ramanathan R, Agarwalla SK. Clinical profile of dengue fever in children: A study from Southern Odisha, India. Scientifica (Cairo) 2016;2016:6391594. doi: 10.1155/2016/6391594.
Guzmán MG, Kouri G, Bravo J, Valdes L, Vazquez S, Halstead SB. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis. 2002 Jun;6(2):118–24. doi: 10.1016/s1201-9712(02)90072-x.
Arlinta D. The trend of death rates due to dengue fever is increasing [Internet]. Jakarta: Kompas.id; 2023 [cited 2024 Jul 29]. Available from: https://www.kompas.id/baca/english/2023/09/08/en-tren-angka-kematian-akibat-dbd-meningkat.
Vinmec International Hospital. Dengue fever: which state is the most dangerous? [Internet]. [cited 2024 Jul 29]. Available from: https://www.vinmec.com/eng/blog/dengue-fever-what-is-the-most-dangerous-stage-en/.
Hanafusa S, Chanyasanha C, Sujirarat D, Khuankhunsathid I, Yaguchi A, Suzuki T. Clinical features and differences between child and adult dengue infections in Rayong Province, southeast Thailand. Southeast Asian J Trop Med Public Health [Internet]. 2008 Mar;39(2):252–9. Available from: https://www.tm.mahidol.ac.th/seameo/2008_39_2/10-4057.pdf.
de Souza LJ, Bastos Pessanha L, Carvalho Mansur L, Assed de Souza L, Barbosa Tamega Ribeiro M, et al. Comparison of clinical and laboratory characteristics between children and adults with dengue. The Brazilian Journal of Infectious Diseases 2013 Jan 1;17(1):27–31. doi: 10.1016/j.bjid.2012.08.020.
Namvongsa V, Sirivichayakul C, Songsithichok S, Chanthavanich P, Chokejindachai W, Sitcharungsi R. Differences in clinical features between children and adults with dengue hemorrhagic fever/dengue shock syndrome. Southeast Asian J Trop Med Public Health [Internet]. 2013 Sep;44(5):772–9. Available from: https://search.tci-thailand.org/article.html?b3BlbkFydGljbGUmaWQ9MTIwNTQx.
Centers for Disease Control and Prevention (CDC). Clinical features of dengue [Internet]. Atlanta (GA): CDC; 2024 [cited 2024 Jul 30]. Available from: https://www.cdc.gov/dengue/hcp/clinical-signs/index.html
Sandinirwan I, Muslim B, Leo H, Hasanah H, Karina PP. Evaluating the importance of clinical manifestations and laboratory parameters associated with progression to severe dengue in children. Paediatrica Indonesiana 2023 Apr 11;63(2):102–18. doi: 10.14238/pi63.2.2023.102-18.
White NJ, Halstead SB. Dengue. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens and practice. Philadelphia: Elsevier; 2011. p. 1257-73.
Deen J, Seidlein L von. Paracetamol for dengue fever: no benefit and potential harm? The Lancet Global Health 2019 May 1;7(5):e552–3. doi: 10.1016/S2214-109X(19)30157-3.
Tayal A, Kabra SK, Lodha R. Management of dengue: an updated review. Indian J Pediatr. 2023;90(2):168–77. doi: 10.1007/s12098-022-04394-8.
Sharma A, Ali M. Prophylactic platelet transfusion in dengue: blanket of false comfort? Natl Med J India. 2018 Jan 1;31:24. doi: 10.4103/0970-258X.243409.
UNICEF South Asia. Dengue: how to keep children safe [Internet]. Kathmandu: UNICEF South Asia [cited 2024 Jul 31]. Available from: https://www.unicef.org/rosa/stories/dengue-how-keep-children-safe.
World Health Organization (WHO). Vaccines and immunization: dengue [Internet]. Geneva: WHO; 2023 [cited 2024 Jul 31]. Available from: https://www.who.int/news-room/questions-and-answers/item/dengue-vaccines.
Utarini A, Indriani C, Ahmad RA, Tantowijoyo W, Arguni E, Ansari MR, et al. Efficacy of Wolbachia-infected mosquito deployments for the control of dengue. N Engl J Med. 2021;384(23):2177–86. doi: 10.1056/NEJMoa2030243.
Manjarres-Suarez A, Olivero-Verbel J. Chemical control of Aedes aegypti: a historical perspective. Revista Costarricense de Salud Publica. 2013;22(1):68–75.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2025 Sonia Sudana Kusuma

Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.